Inventor · disambiguated record
Chengzhi Zhang
Also filed as: ZHANG CHENGZHI
62 granted patents·84 pending applications·287 citations·filing 1996–2024
98Inventor score
Files withAUSPEX PHARMACEUTICALS INC87BAYER PHARMACEUTICALS CORP12DESIGN THERAPEUTICS INC11RAO TADIMETI7ZHANG CHENGZHI5
Top patents by PatentIndex Score
146 records- 0196US10166183B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Jan 1, 2019·22 cites·21 claims
- 0294US10722479B2Dimethoxyphenyl inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jul 28, 2020·7 cites·30 claims
- 0394US9296739B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·21 cites·27 claims
- 0494US9233959B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·22 cites·27 claims
- 0591US8202876B2Compounds and compositions as protein kinase inhibitorsALBAUGH PAMELA·Filed 2007·Granted Jun 19, 2012·39 cites·9 claims
- 0690US10626105B2Deuterium-substituted pyridin- and pyrimidin-2-yl-methylamine compoundsAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted Apr 21, 2020·7 cites·11 claims
- 0790US9814708B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·6 cites·39 claims
- 0890US9346800B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·9 cites·20 claims
- 0989US8299084B2Piperidine inhibitors of Janus kinase 3RAO TADIMETI·Filed 2010·Granted Oct 30, 2012·11 cites·5 claims
- 1089US2024366591A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1188US10513488B2Methods of manufacturing benzoquinoline compoundsAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted Dec 24, 2019·1 cites·37 claims
- 1288US9498481B2Cyclopropyl modulators of P2Y12 receptorAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Nov 22, 2016·5 cites·16 claims
- 1388US8575348B2Quinolone inhibitors of lipoprotein-associated phospholipase A2RAO TADIMETI·Filed 2010·Granted Nov 5, 2013·13 cites·26 claims
- 1487US2025179064A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1586US7511048B2PyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Mar 31, 2009·4 cites·10 claims
- 1685US9255104B2Cyclopropyl modulators of P2Y12 receptorAUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Feb 9, 2016·5 cites·16 claims
- 1783US9585884B2Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted Mar 7, 2017·5 cites·33 claims
- 1883US8802850B2Cyclopropyl modulators of P2Y12 receptorRAO TADIMETI·Filed 2010·Granted Aug 12, 2014·5 cites·5 claims
- 1983US7358386B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Apr 15, 2008·5 cites·2 claims
- 2082US12077487B2Methods of manufacturing benzoquinoline compoundsAUSPEX PHARMACEUTICALS INC·Filed 2022·Granted Sep 3, 2024·0 cites·21 claims
- 2182US9550780B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·4 cites·27 claims
- 2282US6828335B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·15 cites·102 claims
- 2382US2023355514A1Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2481US11033540B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·0 cites·38 claims
- 2580US9018232B2Substituted N-aryl pyridinonesZHANG CHENGZHI·Filed 2012·Granted Apr 28, 2015·4 cites·18 claims
- 2680US7585888B2Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2008·Granted Sep 8, 2009·4 cites·5 claims
- 2779US7384947B2Fused tricyclic heterocycles useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2006·Granted Jun 10, 2008·2 cites·5 claims
- 2878US12502385B2Analogs of deutetrabenazine, their preparation and useAUSPEX PHARMACEUTICALS INC·Filed 2021·Granted Dec 23, 2025·0 cites·8 claims
- 2977US8962638B2Piperidine inhibitors of janus kinase 3AUSPEX PHARMACEUTICALS INC·Filed 2012·Granted Feb 24, 2015·2 cites·2 claims
- 3077US8637524B2Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2RAO TADIMETI·Filed 2010·Granted Jan 28, 2014·3 cites·16 claims
- 3177US8586760B2Aminothiazole modulators of beta-3-adrenoreceptorRAO TADIMETI·Filed 2010·Granted Nov 19, 2013·3 cites·16 claims
- 3277US2021244723A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3376US11179386B2Analogs of deutetrabenazine, their preparation and useAUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Nov 23, 2021·0 cites·22 claims
- 3476US10966922B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·16 claims
- 3576US7112597B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 26, 2006·7 cites·73 claims
- 3674US2021205214A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3774US2018230083A1Methods of manufacturing benzoquinoline compoundsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3874US2022088006A1Analogs of deutetrabenazine, their preparation and useAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3974US2020331846A1Methods of manufacturing benzoquinoline compoundsAUSPEX PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4073US11666566B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 4173US2024042046A1Methods and compounds for modulating huntington's diseaseDESIGN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4273US2020347008A1Methods of manufacturing benzoquinoline compoundsAUSPEX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 4373US2021355120A1Benzoquinolone inhibitors of vmat2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4473US2024058460A1Methods and compounds for modulating huntington's diseaseDESIGN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4573US2022072131A1Dihydroxyphenyl Neurotransmitter Compounds, Compositions And MethodsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4673US2021322308A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4772US7750017B2HeterocyclesBAYER SCHERING PHARMA AG·Filed 2005·Granted Jul 6, 2010·2 cites·10 claims
- 4872US2019092719A1Methods of manufacturing benzoquinoline compoundsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4972US2019133935A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 5071US9029407B2Aminothiazole modulators of beta-3-adrenoreceptorAUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 12, 2015·1 cites·30 claims
Showing the top 50 of 146 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Chengzhi Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →